AMG International

What AMG International does

AMG International is a Germany-based medical device manufacturer headquartered in Winsen, founded in 1997, with a headcount of 51–100 employees. The company specializes in the production of cardiology and peripheral vascular devices, and its detailed product and strategy material is presented under the Q3 Medical Group corporate identity. Its core offering spans two product categories: Biodegradable Products and Peripheral Products, both built around biodegradable and minimally invasive medical device technologies designed to reduce complications, eliminate the need for follow-up removal procedures, shorten hospital stays, and lower overall care costs. The technology is described as a paradigm shift in healthcare treatment, developed through close collaboration with clinicians worldwide and emphasizing sustainability benefits including lower carbon emissions and reduced waste per patient procedure.

The company's business model is B2B hardware sales of medical devices, distributed through direct sales channels targeting hospitals and healthcare institutions globally. The go-to-market motion is sales-led and clinician-led, leveraging partnerships with medical professionals to develop technology tailored to specific patient needs, indicating a consultative enterprise sales approach. Customer segmentation is vertical, addressing two primary segments: hospitals and healthcare institutions seeking to reduce care costs and shorten patient stays, and patients benefiting from reduced complications and faster recoveries. Marketing efforts are concentrated on a corporate website (q3medical.com) with content marketing, library resources, and a news section, while distribution relies on direct field/enterprise sales to healthcare providers.

Name

AMG International

Legal name

Q3 Medical Group

Website

https://amggastro.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

51–100 employees

Short description

AMG International is a German medical device manufacturer founded in 1997, specializing in cardiology and peripheral vascular devices. It sells biodegradable and minimally invasive devices directly to hospitals and healthcare providers worldwide through a clinician-led commercial model.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Coronary Stents & Drug-Eluting Technologies (HLAHAFAA)

akta.pro secondary industries

Interventional Cardiology (PCI/Structural Heart) (HLAKABAB), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Cardiology medical devices
• Peripheral vascular devices
• Biodegradable medical devices
• Minimally invasive devices
• Gastroenterology devices

Headquarters

HQ city

Winsen

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Revenue generated from the sale of biodegradable and peripheral medical devices to hospitals, healthcare providers, and clinical settings. The company develops products that reduce overall care costs for hospitals, patients, and healthcare providers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

AMG International manufactures cardiology and peripheral vascular medical devices, with a portfolio centered on biodegradable and minimally invasive technologies. The products are designed to reduce post-procedure complications, eliminate secondary removal procedures, and shorten hospital stays for patients treated in hospital and clinical settings.

Product overview

Q3 Medical Group offers two core product categories: Biodegradable Products and Peripheral Products. Both product lines utilize biodegradable and minimally invasive technologies that prioritize patient outcomes by reducing complications, eliminating removal procedures, shortening hospital stays, and lowering overall healthcare costs. The company's multidisciplinary approach develops technology tailored to clinician and patient needs, creating streamlined patient pathways for swift recoveries.

Differentiator

Problem solved

Functional benefit

Brands

• Biodegradable: Biodegradable medical products and technologies
• Peripheral

Products and services

• Biodegradable Products A line of biodegradable medical devices intended to perform their clinical function and then be absorbed by the body, designed to reduce post-procedure complications, eliminate the need for secondary device removal, and shorten hospital stays. Targeted at hospitals and clinicians performing cardiology and gastroenterology procedures.
• Peripheral Products A line of peripheral vascular medical devices focused on minimally invasive approaches for treating peripheral vascular conditions. Targeted at hospitals, vascular surgeons, and interventional cardiology teams.

Quantifiable outcome

• Shortened hospital stays through streamlined patient pathways
• +2 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• Terumo: Japanese-headquartered global medical device company with a strong peripheral vascular and interventional systems portfolio. Comparable product categories and hospital sales model, though much larger and geographically broader.
• Biotronik: Germany-based privately-held medical device company specializing in cardiovascular and endovascular solutions including stents and vascular intervention devices. Closely comparable to AMG given shared German heritage, cardiology/vascular focus, and private mid-sized profile.

Broad incumbents

• B. Braun: Large German medical device and pharmaceutical company with a significant vascular and interventional product portfolio. Comparable as a German-headquartered medical device peer operating in vascular access and minimally invasive devices, though far larger and broader.
• Abbott Vascular: Global leader in coronary stents (including the historical Absorb bioresorbable scaffold) and peripheral vascular devices. Directly comparable category and competitive set, though vastly larger and incumbent in biodegradable vascular scaffolds.
• Medtronic: World's largest medical device company with a deep coronary and peripheral vascular portfolio including drug-eluting stents. Directly competes in AMG's target categories and sets the clinical evidence bar.
• Cordis (Cardinal Health): Cardiovascular and endovascular device manufacturer with coronary and peripheral vascular product lines. Direct product overlap with AMG's cardiology/peripheral focus.
• Boston Scientific: Major cardiology and peripheral vascular intervention device manufacturer with global hospital sales channels. Comparable product overlap in stents, peripheral devices, and minimally invasive technologies.

Emerging players

• REVA Medical: Developer of bioresorbable polymer-based scaffolds for vascular applications. Most directly comparable peer in terms of biodegradable technology differentiation, though at a different stage of development.
• InspireMD: Specialist in embolic prevention and stroke-intervention devices with a focus on minimally invasive vascular technologies. Comparable in being a smaller, focused player in adjacent vascular device niches.
• Elixir Medical: Developer of next-generation bioresorbable scaffold systems and drug-eluting technologies for vascular applications. Comparable as a focused biodegradable vascular device specialist.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/amg_gastro
• LinkedInlinkedin.com/company/q3-medical-group

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMG International